If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.75
Bid: 3.50
Ask: 4.00
Change: 0.00 (0.00%)
Spread: 0.50 (14.286%)
Open: 3.75
High: 3.75
Low: 3.75
Prev. Close: 3.75
PRIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Note Investment - Zuuse Pty Ltd

16 Oct 2018 07:00

RNS Number : 1230E
Primorus Investments PLC
16 October 2018
 

Primorus Investments plc

("Primorus" or the "Company")

 Loan Note Investment - Zuuse Pty Ltd

 

Primorus Investments plc (AIM: PRIM, NEX: PRIM) is pleased to report that it has invested A$500,000 (circa £272,000) in a fully subscribed A$5m Series B Loan Note to an Australian-based, international construction software and payments company Zuuse Pty Ltd ("Zuuse"). The Series B Loan Note has a 12-month term, yielding an attractive coupon of 12% and the added attraction of free attaching options over approximately 0.8% of Zuuse which expire on 30 September 2021.

 

Zuuse is based in Australia with offices in the UK and the US and has two core platforms, Zuuse Construction and Zuuse Building Operations. Through its sub-brand Zuuse Lifecycle, it services a significant number of assets across Australia and the UK including hospitals, universities, hotels, office blocks, bridges and sports stadiums. Through its Payapps and GC Pay Brands, Zuuse services small, medium and large construction companies as well as thousands of subcontractor groups and facilitates over A$12B in annualised payment values across its platforms.

 

With forecast global revenues growing at circa 60% per annum, Zuuse has, in 2019, forecast revenues of A$16A$18m and a positive EBITDA of A$3m to A$5m.

 

Alastair Clayton, Executive Director of Primorus, is a circa 2.75% shareholder of Zuuse and therefore did not participate in the board decision to approve this investment.

 

Further information on can be found at:

www.zuuse.com

www.payapps.com

www.gcpay.com

 

Jeremy Taylor-Firth, Non-Executive Chairman Commented;

 

"I am pleased that we have been able to participate in this fully subscribed A$5m Series B 12 month Loan Note. The rationale behind the investment was to manage short to medium term cash reserves in a more efficient manner and the 12% coupon for the risk-profile was highly attractive on its own right. That we also receive options over approximately 0.8% of Zuuse is a real bonus and gives us a longer-term stake in what is a rapidly growing global software business."

 

He added;

 

"As will be evidenced in our soon to be released Quarter 3 report to shareholders, Primorus has a debt-free balance sheet with cash reserves and liquid shares comprising a very large proportion of its current quoted market value. Our core value proposition is a multi-million pound portfolio of private and pre-IPO investments built over the last 18 months. The portfolio is beginning to mature to the point where we can see potential investment exits on the horizon and the Board believes that the best way to deliver tangible shareholder value is to demonstrate profitable exits to grow the share price and once we have built a larger balance sheet to support ongoing investing, return excess cash to shareholders."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information, please contact:

Primorus Investments plc:

+44 (0) 20 7440 0640

Alastair Clayton

Nominated Adviser:

+44 (0) 20 7213 0880

Cairn Financial Advisers LLP

James Caithie / Sandy Jamieson

Broker:

+44 (0) 20 3621 4120

Turner Pope Investments

Andy Thacker

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDXBDGIGBBGIU
Date   Source Headline
15th Apr 20247:00 amRNSInvestee Company Update – Engage Technology
25th Mar 20247:00 amRNSHolding(s) in Company
25th Mar 20247:00 amRNSHolding(s) in Company
19th Mar 20242:45 pmRNSFurther re Dividend Declaration
11th Mar 20244:51 pmRNSDividend Declaration
8th Mar 202411:49 amRNSFurther Investment in Fresho Pty Ltd
27th Feb 20247:00 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSInvestee Company Update – Payapps Limited
2nd Feb 20243:26 pmRNSHolding(s) in Company
26th Jan 20247:00 amRNSInvestee Company Update – Payapps Limited
11th Oct 20239:59 amRNSDirector/PDMR Shareholding
28th Sep 20235:27 pmRNSDirector/PDMR Shareholding
19th Sep 20234:50 pmRNSHolding(s) in Company
15th Sep 20237:41 amRNSFurther re Investment in Interpac & Bushveld CLN
18th Aug 20233:12 pmRNSHalf-year Report
15th Aug 202312:06 pmRNSResult of AGM
2nd Aug 202310:25 amRNSAlteration Earth - Investment Update
20th Jul 20237:00 amRNSNotice of AGM
14th Jul 20234:00 pmRNSBushveld Convertible Loan Note Update
20th Jun 20237:00 amRNSConsent to Electronic Communication
16th Jun 20233:18 pmRNSFinal Results
16th Mar 20232:50 pmRNSDirector/PDMR Shareholding
19th Jan 20233:25 pmRNSHolding(s) in Company
19th Jan 20233:23 pmRNSDirector/PDMR Shareholding
8th Dec 20227:01 amRNSHolding(s) in Company
8th Dec 20227:00 amRNSDirector/PDMR Shareholding
2nd Dec 20227:00 amRNSDirector/PDMR Shareholding
29th Nov 202211:05 amRNSSecond Price Monitoring Extn
29th Nov 202211:00 amRNSPrice Monitoring Extension
13th Sep 20223:50 pmRNSInvestment in Interpac Ltd
2nd Sep 20222:00 pmRNSHalf-year Report
1st Jul 20228:23 amRNSInvestment Update
30th Jun 202210:43 amRNSResult of AGM
10th Jun 20223:00 pmRNSFinal Results
6th Jun 202211:39 amRNSUpdate on Alteration Earth PLC Investment
31st May 20223:58 pmRNSNotice of AGM
4th May 202212:33 pmRNSUpdate on Alteration Earth PLC Investment
5th Apr 20227:00 amRNSUpdate on Alteration Earth PLC Investment
30th Mar 20228:12 amRNSDirector/PDMR Shareholding
29th Mar 20227:00 amRNSFurther re Investment in Mustang
17th Mar 20224:12 pmRNSFurther Investment in Rambler Metals & Mining PLC
16th Mar 20221:05 pmRNSCancellation of Share Options
8th Mar 202210:48 amRNSUpdate on Alteration Earth PLC Investment
28th Feb 20224:45 pmRNSFurther re Investment in Mustang
16th Feb 20227:00 amRNSGeneral Update & Clean Power Hydrogen Investment
3rd Feb 20227:00 amRNSInvestment in Rambler Metals & Mining PLC
31st Jan 202210:54 amRNSAlteration Earth Update
19th Jan 20228:01 amRNSFurther re Investment in Mustang
24th Dec 202110:11 amRNSAlteration Earth update
21st Dec 20217:00 amRNSUpdate on Mustang Energy Investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.